Vaccine production continues to buoy pharma prospects

Global pharmaceutical production maintained its solid upward trend in Q4 2020. During 2021, robust vaccine production prospects, especially in those countries involved in R&D of COVID-19 vaccines, will boost pharmaceuticals production. In addition, the gradual improvement in economic conditions and recovering healthcare spending will underpin production growth ahead. We forecast global pharma production growth of 6.4% in 2021.

What you will learn:

  • In the US, we expect pharma production to post robust growth of 6.7% in 2021. Vaccine production prospects are solid, and President Biden appears to be in favour of encouraging onshoring.
  • In China, robust pharma demand drove a huge increase in production towards the end of 2020. We expect activity to remain strong in 2021, supported by vaccine production and solid healthcare demand.
  •  There are some considerable risks to the outlook.
If you request more charts please click here to request a free trial.

Topics: Manufacturing, Industry, Pharmaceuticals, Sector Trends, Vaccines